Zoetis (ZTS) Exchange Rate Effect (2012 - 2026)
Zoetis' (ZTS) quarterly Exchange Rate Effect came in at $17.0 million in Q1 2026, down 48.48% year-on-year from $33.0 million in Q1 2025, and up 525.0% on a QoQ basis from -$4.0 million in Q4 2025.
Zoetis (ZTS) Exchange Rate Effect (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Exchange Rate Effect data on file, last reported at $17.0 million in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 48.48% year-over-year to $17.0 million in Q1 2026; TTM through Mar 2026 was $23.0 million, a 228.57% increase from a year earlier, with the FY2025 full-year figure at $39.0 million, up 221.88% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $17.0 million, up from -$4.0 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for ZTS reached as high as $33.0 million in Q1 2025 and fell as low as -$18.0 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$750000.0 across 5 years, with a median of -$3.5 million in 2023.
- Across the five-year window, Exchange Rate Effect tumbled 700.0% in 2024 and jumped 650.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$9.0 million in 2022, then surged by 66.67% to -$3.0 million in 2023, then plunged by 333.33% to -$13.0 million in 2024, then soared by 69.23% to -$4.0 million in 2025, then soared by 525.0% to $17.0 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $17.0 million in Q1 2026, -$4.0 million in Q4 2025, and $5.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.00 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 33.00 Mn |
| Mar 31, 2025 | 33.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -8.00 Mn |
| Jun 30, 2024 | -8.00 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |